menu
    • menu

    Company profile for ExeGi

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ExeGi Pharma develops live biotherapeutic and probiotic medicines for a wide variety of therapeutic needs. Our team consists of experts in the field with extensive product and clinical development, manufacturing, and commercialization of live biotherapeutics and probiotics. ExeGi Pharma is a biotechnology company focused on the development and commercialization of live biotherapeutic and probiotic medicines. Our team leverages...
    ExeGi Pharma develops live biotherapeutic and probiotic medicines for a wide variety of therapeutic needs. Our team consists of experts in the field with extensive product and clinical development, manufacturing, and commercialization of live biotherapeutics and probiotics. ExeGi Pharma is a biotechnology company focused on the development and commercialization of live biotherapeutic and probiotic medicines. Our team leverages the field of microbiome science to deliver novel, clinically supported, live biotherapeutic and probiotic treatments for a variety of unmet medical needs for both humans and veterinary applications.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ExeGiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    155 Gibbs St, Rockville, Maryland 20850
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://exegipharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/exegi-pharma-llc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ExeGiPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346
    ExeGi Pharma announces first patient enrollment in the PROF Trial of EXE-346

    10 Dec 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/exegi-pharma-announces-first-patient-enrollment-in-the-prof-trial-of-exe-346-14997

    INDIAN PHARMA POST
    10 Dec 2023
    Share Share
    ExeGi Pharma Announces First Patient Enrollment in the PROF Trial of EXE-346
    ExeGi Pharma Announces First Patient Enrollment in the PROF Trial of EXE-346

    08 Dec 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/exegi-pharma-announces-first-patient-enrollment-in-the-prof-trial-of-exe-346-302009573.html

    PR NEWSWIRE
    08 Dec 2023
    Share Share
    ExeGi Pharma Announces Clearance of IND Application for EXE-346
    ExeGi Pharma Announces Clearance of IND Application for EXE-346

    26 Jan 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/exegi-pharma-announces-clearance-of-investigational-new-drug-ind-application-for-exe--46-a-live-biotherapeutic-biologic-drug-301732108.html

    PR NEWSWIRE
    26 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search